In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy.
about
Reciprocal role of cyclins and cyclin kinase inhibitor p21WAF1/CIP1 on lymphocyte proliferation, allo-immune activation and inflammation.Gene therapy for head and neck cancer.Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significanceExpression, deletion [was deleton] and mutation of p16 gene in human gastric cancerA dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate.Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension.Recombinant adenovirus-p21 attenuates proliferative responses associated with excessive scarring.
P2860
Q24814290-60B6D59A-EA72-4F69-887E-7E0E8CA5FC02Q33916453-3C363AC7-1493-4D52-8C7D-4433A347E6DBQ35010835-0A875AD7-200D-4D1E-9EEC-97E09A5A17CDQ36397218-2503DD7A-7964-45D3-92F6-FC9AE7543DB0Q39981678-171955E3-B928-456A-8175-AB908F1C86D7Q45873239-42584391-04FD-40A7-A167-0D20CA1056D7Q46311823-1E18A86D-2614-4F9E-B5F8-48ED35BDE061
P2860
In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
In vitro growth suppression by ...... for combination gene therapy.
@en
In vitro growth suppression by ...... for combination gene therapy.
@nl
type
label
In vitro growth suppression by ...... for combination gene therapy.
@en
In vitro growth suppression by ...... for combination gene therapy.
@nl
prefLabel
In vitro growth suppression by ...... for combination gene therapy.
@en
In vitro growth suppression by ...... for combination gene therapy.
@nl
P2093
P1433
P1476
In vitro growth suppression by ...... for combination gene therapy.
@en
P2093
P356
10.1001/ARCHOTOL.124.1.88
P577
1998-01-01T00:00:00Z